Development and validation of a high-performance liquid chromatography-tandem mass spectrometry for the determination of penciclovir in human plasma: Application to a bioequivalence study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 852, Issue 1-2, 2007, Pages 382-388

  Lee, Heon Woo ^a   Seo, Ji Hyung ^a   Lee, Kyung Tae ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Acyclovir; Bioequivalence study; Famciclovir; Human plasma; LC MS MS; Penciclovir

Indexed keywords

BIOEQUIVALENCE STUDY; FAMCICLOVIR; LOWER LIMIT OF QUANTIFICATION (LLOQ); PENCICLOVIR;

AMMONIUM COMPOUNDS; FORMIC ACID; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PH EFFECTS; PLASMA (HUMAN);

DRUG PRODUCTS;

ACICLOVIR; FAMCICLOVIR; PENCICLOVIR;

ARTICLE; BIOEQUIVALENCE; DRUG BLOOD LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MONITORING; NORMAL HUMAN; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ACYCLOVIR; ANTIVIRAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; THERAPEUTIC EQUIVALENCY;

EID: 34249730013     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.01.044     Document Type: Article

References (20)

1. Boyd M.R., Bacon T.H., Sutton D., and Cole M. Antimicrob. Agents Chemother. 31 (1987) 1238
2. Boyd M.R., Bacon T.H., and Sutton D. Antimicrob. Agents Chemother. 32 (1988) 358
3. Harnden M.R., Jarvest R.L., Bacon T.H., and Boyd M.R. J. Med. Chem. 30 (1987) 1636
4. Sutton D., and Boyd M.R. Antimicrob. Agents Chemother. 37 (1993) 642
5. Korba B.E., and Boyd M.R. Antimicrob. Agents Chemother. 40 (1996) 1282
6. Boyd M.R., Boon R., Fowles S.E., Pagano K., Sutton D., Vere Hodge R.A., and Zussman B.D. Antiviral Res. 9 (1988) 146
7. Harnden M.R., Jarvest R.L., Boyd M.R., Sutton D., and Vere Hodge R.A. J. Med. Chem. 32 (1989) 1738
8. Vere Hodge R.A., Sutton D., Boyd M.R., Harnden M.R., and Jarvest R.L. Antimicrob. Agents Chemother. 33 (1989) 1765
9. Pue M.A., and Benet L.Z. Antiviral Chem. Chemother. 4 (1993) 47
10. Filer C.W., Ramji J.V., Allen G.D., Brown T.A., Fowles S.E., Hollis F.J., and Mort E.E. Xenobiotica 25 (1995) 477
11. Loregian A., Gatti R., Palù G., and De Palo E.F. J. Chromatogr. B 764 (2001) 289
12. Filer C.W., Allen G.D., Brown G.D., Fowles S.E., Hollis F.J., Mort E.E., Prince W.T., and Ramji J.V. Xenobiotica 24 (1994) 357
13. Pue M.A., Pratt S.K., Fairless A.J., Fowles S.E., Laroche J., Georgiou P., and Prince W.T. J. Antimicrob. Chemother. 33 (1994) 119
14. Boike S.C., Pue M., Freed M.I., Audet P.R., Fairless A., Ilson B.E., Zariffa N., and Jorkasky D.K. Xenobiotica 55 (1994) 418
15. Kim D.K., Lee N., Ryu D.H., Kim Y.W., Kim J.S., Chang K., Im G.J., Choi W.S., Cho Y.B., Kim K.H., Colledge D., and Locarnini S. Bioorg. Med. Chem. 7 (1999) 1715
16. Fowles S.E., and Pierce D.M. Analyst 114 (1989) 1373
17. Puea M.A., Pratta S.K., Fairlessa A.J., Fowlesa S., Larochea J., Georgioub P., and Princec W. J. Antimicrob. Chemother. 33 (1994) 119
18. Schenkel F., Rudaz S., Daali Y., Kondo Oestreicher M., Veuthey J.L., and Dayer P. J. Chromatogr. B 826 (2005) 1
19. KFDA Guidance for Industry, Statistical Approaches to Establishing Bioequivalence, Bioequivalence Division, Pharmacology Department, National Institute of Toxicology Department, 2003, http://ezdrug.kfda.go.kr/kfda2.
20. Lee Y.J., Kim Y.G., Lee M.G., Chung S.J., Lee M.H., and Shim C.K. Yakhakhoeji 44 (2000) 308